BioSpace News Archive

Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making.

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the second quarter ended June 30, 2019 and provided key business updates.

US Med-Equip, which partners with top hospitals across the nation to provide the highest quality movable medical equipment, is again named as one of the nation’s fastest-growing private companies in Inc. magazine’s annual Inc. 5000 list.

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2019.

Huntington Hospital announced that local philanthropists, Terri and Jerry Kohl have made a gift of $7 million to support the expansion of its new Huntington Heart and Vascular Center.

Cardax, Inc. announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of up to $15 million of the Company’s common stock and warrants.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) today announced its financial results for the first quarter ended June 30, 2019

Deciphera Pharmaceuticals, Inc. announced the pricing of its previously announced registered underwritten public offering of 10,810,810 shares of its common stock at a price to the public of $37.00 per share.

Dr. Jo Varshney, a multi-disciplinary and celebrated leader in veterinary and human health development, along with a team of world class scientists and engineers in machine learning and in silico simulation bring clarity to drug development through better science.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019.